SCHEMBL10044323

SCHEMBL10044323

C=CC(=O)OCCCCCCOC(=O)c1cc(I)cc(I)c1I

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.51
ALDH1A1 P00352 4/20 0.51
CYP3A4 P08684 2/20 0.51
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
HPGD P15428 1/20 0.41
ESR1 P03372 2/20 0.39
TP53 P04637 3/20 0.37
HIF1A Q16665 2/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20214256 1.00 TSHR (0.51) TSHRALDH1A1CYP3A4HDAC3HDAC4
SCHEMBL16295375 1.00 TSHR (0.51) TSHRALDH1A1CYP3A4HDAC3HDAC4
SCHEMBL10044313 0.93 TSHR (0.43) TSHRALDH1A1CYP3A4HDAC3HDAC4
SCHEMBL24196689 0.82 TSHR (0.49) TSHRALDH1A1CYP3A4HPGDESR1
SCHEMBL19678496 0.81 HDAC3 (0.50) TSHRALDH1A1CYP3A4HDAC3HDAC4
SCHEMBL19683949 0.81 HDAC3 (0.50) TSHRALDH1A1CYP3A4HDAC3HDAC4
SCHEMBL21911763 0.80 HDAC3 (0.43) TSHRALDH1A1CYP3A4HDAC3HDAC4
SCHEMBL21842558 0.80 TSHR (0.41) TSHRALDH1A1CYP3A4HPGDESR1
SCHEMBL19678503 0.79 HDAC3 (0.48) TSHRALDH1A1CYP3A4HDAC3HDAC4
SCHEMBL26586766 0.79 HDAC3 (0.41) TSHRALDH1A1CYP3A4HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10814042-B2 Radiopaque polymers for medical devices ENDOSHAPE, INC. (US) 2020-10-27 US disclosed
EP-2953650-B1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES ENDOSHAPE INC (US) 2020-09-30 EP disclosed
EP-3482776-B1 RADIOPAQUE SHAPE MEMORY POLYMERS FOR MEDICAL DEVICES ENDOSHAPE INC (US) 2020-07-15 EP disclosed
US-10590218-B2 Polymer compositions with enhanced radiopacity ENDOSHAPE, INC. (US) 2020-03-17 US disclosed
US-20200061252-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES EMBOLIZATION, INC. 2020-02-27 US disclosed
US-10434223-B2 Radiopaque polymers for medical devices ENDOSHAPE, INC. (US) 2019-10-08 US disclosed
EP-3482776-A1 RADIOPAQUE SHAPE MEMORY POLYMERS FOR MEDICAL DEVICES Endoshape, Inc. (US) 2019-05-15 EP disclosed
EP-2968620-B1 POLYMER COMPOSITIONS WITH ENHANCED RADIOPACITY ENDOSHAPE INC (US) 2019-02-13 EP disclosed
US-20180126045-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES EMBOLIZATION, INC. 2018-05-10 US disclosed
US-20180126045-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES EMBOLIZATION, INC. 2018-05-10 US disclosed
US-20160024239-A1 POLYMER COMPOSITIONS WITH ENHANCED RADIOPACITY EMBOLIZATION, INC. 2016-01-28 US disclosed
US-20150374884-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES EMBOLIZATION, INC. 2015-12-31 US disclosed
US-20150374884-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES EMBOLIZATION, INC. 2015-12-31 US disclosed
US-9062141-B2 Radiopaque shape memory polymers for medical devices ENDOSHAPE, INC. (US) 2015-06-23 US disclosed
US-9062141-B2 Radiopaque shape memory polymers for medical devices ENDOSHAPE, INC. (US) 2015-06-23 US disclosed
WO-2014200594-A1 POLYMER COMPOSITIONS WITH ENHANCED RADIOPACITY ENDOSHAPE, INC. (US) 2014-12-18 WO disclosed
WO-2014124225-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES ENDOSHAPE, INC. (US) 2014-08-14 WO disclosed
US-20130225778-A1 RADIOPAQUE SHAPE MEMORY POLYMERS FOR MEDICAL DEVICES EMBOLIZATION, INC. 2013-08-29 US disclosed
US-20130225778-A1 RADIOPAQUE SHAPE MEMORY POLYMERS FOR MEDICAL DEVICES EMBOLIZATION, INC. 2013-08-29 US disclosed
WO-2012019145-A1 RADIOPAQUE SHAPE MEMORY POLYMERS FOR MEDICAL DEVICES ENDOSHAPE, INC. (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180126045-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES PARN, MMS19, RAD50 TSHR 2016/4885ALDH1A1 4691/4885CYP3A4 4396/4885
US-10590218-B2 Polymer compositions with enhanced radiopacity PARN, PARG, RAD50 TSHR 4094/4885ALDH1A1 4687/4885CYP3A4 4832/4885
US-10814042-B2 Radiopaque polymers for medical devices PARN, MMS19, RAD50 TSHR 2016/4885ALDH1A1 4691/4885CYP3A4 4396/4885
US-20200061252-A1 RADIOPAQUE POLYMERS FOR MEDICAL DEVICES PARN, MMS19, RAD50 TSHR 2016/4885ALDH1A1 4691/4885CYP3A4 4396/4885
US-10434223-B2 Radiopaque polymers for medical devices PARN, MMS19, RAD50 TSHR 2016/4885ALDH1A1 4691/4885CYP3A4 4396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.